
Dr Stephen Ryder
Queens Medical Centre Campus, Derby Road, Nottingham, NG7 2UH
stephen.ryder@nuh.nhs.uk View full bio
Consultant Physician in Hepatology and Gastroenterology
Studies
Title | Start Date | Status |
---|---|---|
IL-1 Signal Inhibition in Alcoholic Hepatitis | 28th May 2019 | Active |
A phase I, randomised, double-blind, placebo-controlled, multi-centre, ascending-dose trial to evalu | 1st May 2016 | Active |
An open label single arm study to investigate the safety and efficacy of multiple administartions of | 1st September 2011 | Ended |
Does addition of metformin to standard combination therapy increase sustained response rates for pat | 1st August 2011 | Ended |
Ancillary study evaluating ChAd155-hIi-HBV shedding in a subset of chronic hepatitis B patients enro | 19th February 2020 | Active |
A Phase 2a, Randomized, Partially-blind, Placebo-controlled Study to Assess the Efficacy, Safety, an | 21st May 2018 | Active |
A randomized, double-blind, placebo-controlled, multicenter, dose-range, proof-of-concept, 24-week t | 10th July 2018 | Active |
Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) | 2nd March 2017 |
Publications